These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16030358)

  • 21. The gastrointestinal safety of the COX-2 selective inhibitor etoricoxib assessed by both endoscopy and analysis of upper gastrointestinal events.
    Hunt RH; Harper S; Watson DJ; Yu C; Quan H; Lee M; Evans JK; Oxenius B
    Am J Gastroenterol; 2003 Aug; 98(8):1725-33. PubMed ID: 12907325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prevention of gastropathy and upper abdominal symptoms caused by nonsteroidal anti-inflammatory drugs.
    Vakil N
    Rev Gastroenterol Disord; 2006; 6(4):221-6. PubMed ID: 17224894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of upper gastrointestinal bleeding with oral bisphosphonates and non steroidal anti-inflammatory drugs: a case-control study.
    Etminan M; Lévesque L; Fitzgerald JM; Brophy JM
    Aliment Pharmacol Ther; 2009 Jun; 29(11):1188-92. PubMed ID: 19298582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 'Generally safe' NSAIDs?
    Rosen Z
    Am Fam Physician; 2001 Feb; 63(4):637. PubMed ID: 11237080
    [No Abstract]   [Full Text] [Related]  

  • 25. Performance of the High-dimensional Propensity Score in a Nordic Healthcare Model.
    Hallas J; Pottegård A
    Basic Clin Pharmacol Toxicol; 2017 Mar; 120(3):312-317. PubMed ID: 27889951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonsteroidal antiinflammatory drug use among patients with GI bleeding.
    Dominick KL; Bosworth HB; Jeffreys AS; Grambow SC; Oddone EZ; Horner RD
    Ann Pharmacother; 2004; 38(7-8):1159-64. PubMed ID: 15187205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonsteroidal anti-inflammatory drugs and lower gastrointestinal complications.
    Lanas A; Sopeña F
    Gastroenterol Clin North Am; 2009 Jun; 38(2):333-52. PubMed ID: 19446262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of cyclo-oxygenase 2 inhibitors (COX-2) and prescription non-steroidal anti-inflammatory drugs (NSAIDS) in UK and USA populations. Implications for COX-2 cardiovascular profile.
    Arellano FM; Yood MU; Wentworth CE; Oliveria SA; Rivero E; Verma A; Rothman KJ
    Pharmacoepidemiol Drug Saf; 2006 Dec; 15(12):861-72. PubMed ID: 17086563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lower GI bleeding risk of nonsteroidal anti-inflammatory drugs and antiplatelet drug use alone and the effect of combined therapy.
    Nagata N; Niikura R; Aoki T; Shimbo T; Kishida Y; Sekine K; Tanaka S; Okubo H; Watanabe K; Sakurai T; Yokoi C; Akiyama J; Yanase M; Mizokami M; Uemura N
    Gastrointest Endosc; 2014 Dec; 80(6):1124-31. PubMed ID: 25088922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular safety of non-steroidal anti-inflammatory drugs among healthy individuals.
    Fosbøl EL; Køber L; Torp-Pedersen C; Gislason GH
    Expert Opin Drug Saf; 2010 Nov; 9(6):893-903. PubMed ID: 20569079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The safety of opioid analgesics in the elderly: new data raise new concerns: comment on "The comparative safety of opioids for nonmalignant pain in older adults".
    Becker WC; O'Connor PG
    Arch Intern Med; 2010 Dec; 170(22):1986-8. PubMed ID: 21149755
    [No Abstract]   [Full Text] [Related]  

  • 32. Arthritis in older adults.
    Luggen AS
    Geriatr Nurs; 2001; 22(3):118. PubMed ID: 11410760
    [No Abstract]   [Full Text] [Related]  

  • 33. Application of a propensity score to adjust for channelling bias with NSAIDs.
    Morant SV; Pettitt D; MacDonald TM; Burke TA; Goldstein JL
    Pharmacoepidemiol Drug Saf; 2004 Jun; 13(6):345-53. PubMed ID: 15170763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of claims-based diagnostic and procedure codes for cardiovascular and gastrointestinal serious adverse events in a commercially-insured population.
    Wahl PM; Rodgers K; Schneeweiss S; Gage BF; Butler J; Wilmer C; Nash M; Esper G; Gitlin N; Osborn N; Short LJ; Bohn RL
    Pharmacoepidemiol Drug Saf; 2010 Jun; 19(6):596-603. PubMed ID: 20140892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gastrointestinal bleeding after the introduction of COX 2 inhibitors: ecological study.
    Mamdani M; Juurlink DN; Kopp A; Naglie G; Austin PC; Laupacis A
    BMJ; 2004 Jun; 328(7453):1415-6. PubMed ID: 15138157
    [No Abstract]   [Full Text] [Related]  

  • 36. NSAID-associated lower gastrointestinal bleeding: where do we stand?
    Chan FK
    Clin Gastroenterol Hepatol; 2012 Oct; 10(10):1060-1. PubMed ID: 22864228
    [No Abstract]   [Full Text] [Related]  

  • 37. Incidence and possible risk factors for clinical upper gastrointestinal events in patients taking selective cyclooxygenase-2 inhibitors: A prospective, observational, cohort study in Taiwan.
    Hsiang KW; Chen TS; Lin HY; Luo JC; Lu CL; Lin HC; Lee KC; Chang FY; Lee SD
    Clin Ther; 2010 Jul; 32(7):1294-303. PubMed ID: 20678677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preventing non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: are older strategies more cost-effective in the general population?
    Elliott RA; Hooper L; Payne K; Brown TJ; Roberts C; Symmons D
    Rheumatology (Oxford); 2006 May; 45(5):606-13. PubMed ID: 16368733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [NSAIDs digestive risk: epidemiologic data].
    Ravaud P; Chaussade S
    Presse Med; 2003 Nov; 32(37 Pt 2):S5-8. PubMed ID: 14763348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-steroidal anti-inflammatory drugs use and risk of upper gastrointestinal adverse events in cirrhotic patients.
    Lee YC; Chang CH; Lin JW; Chen HC; Lin MS; Lai MS
    Liver Int; 2012 May; 32(5):859-66. PubMed ID: 22226322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.